These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 1836100)

  • 1. Rationale, design and baseline characteristics of the survival and ventricular enlargement trial. SAVE Investigators.
    Moyé LA; Pfeffer MA; Braunwald E
    Am J Cardiol; 1991 Nov; 68(14):70D-79D. PubMed ID: 1836100
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of captopril on ischemic events after myocardial infarction. Results of the Survival and Ventricular Enlargement trial. SAVE Investigators.
    Rutherford JD; Pfeffer MA; Moyé LA; Davis BR; Flaker GC; Kowey PR; Lamas GA; Miller HS; Packer M; Rouleau JL
    Circulation; 1994 Oct; 90(4):1731-8. PubMed ID: 7923656
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the survival and ventricular enlargement trial. The SAVE Investigators.
    Pfeffer MA; Braunwald E; Moyé LA; Basta L; Brown EJ; Cuddy TE; Davis BR; Geltman EM; Goldman S; Flaker GC
    N Engl J Med; 1992 Sep; 327(10):669-77. PubMed ID: 1386652
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reduction of ischemic events with angiotensin-converting enzyme inhibitors: lessons and controversy emerging from recent clinical trials.
    Young JB
    Cardiovasc Drugs Ther; 1995 Feb; 9(1):89-102. PubMed ID: 7786840
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Captopril adjuvant therapy to beta-blockers and nitrates improves post-myocardial infarction left ventricular performance.
    Kyriakidis M; Antonopoulos A; Georgiou E; Santas P; Bakirtzis C; Toutouzas P
    Eur Heart J; 1996 Jun; 17(6):864-73. PubMed ID: 8781825
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of enalapril versus captopril on left ventricular function and survival three months after acute myocardial infarction (the "PRACTICAL" study).
    Foy SG; Crozier IG; Turner JG; Richards AM; Frampton CM; Nicholls MG; Ikram H
    Am J Cardiol; 1994 Jun; 73(16):1180-6. PubMed ID: 8203335
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of angiotensin-converting enzyme inhibitors on ventricular remodeling and survival following myocardial infarction.
    Beckwith C; Munger MA
    Ann Pharmacother; 1993 Jun; 27(6):755-66. PubMed ID: 8329800
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of captopril treatment on left ventricular remodeling and function after anterior myocardial infarction: comparison with digitalis.
    Bonaduce D; Petretta M; Arrichiello P; Conforti G; Montemurro MV; Attisano T; Bianchi V; Morgano G
    J Am Coll Cardiol; 1992 Mar; 19(4):858-63. PubMed ID: 1531993
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of captopril on progressive ventricular dilatation after anterior myocardial infarction.
    Pfeffer MA; Lamas GA; Vaughan DE; Parisi AF; Braunwald E
    N Engl J Med; 1988 Jul; 319(2):80-6. PubMed ID: 2967917
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of losartan and captopril on left ventricular volumes in elderly patients with heart failure: results of the ELITE ventricular function substudy.
    Konstam MA; Patten RD; Thomas I; Ramahi T; La Bresh K; Goldman S; Lewis W; Gradman A; Self KS; Bittner V; Rand W; Kinan D; Smith JJ; Ford T; Segal R; Udelson JE
    Am Heart J; 2000 Jun; 139(6):1081-7. PubMed ID: 10827391
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Absence of a deleterious effect of calcium channel blockers in patients with left ventricular dysfunction after myocardial infarction: The SAVE Study Experience. SAVE Investigators. Survival and Ventricular Enlargement.
    Hager WD; Davis BR; Riba A; Moye LA; Wun CC; Rouleau JL; Lamas GA; Pfeffer MA
    Am Heart J; 1998 Mar; 135(3):406-13. PubMed ID: 9506325
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quantitative two-dimensional echocardiographic measurements are major predictors of adverse cardiovascular events after acute myocardial infarction. The protective effects of captopril.
    St John Sutton M; Pfeffer MA; Plappert T; Rouleau JL; Moyé LA; Dagenais GR; Lamas GA; Klein M; Sussex B; Goldman S
    Circulation; 1994 Jan; 89(1):68-75. PubMed ID: 8281697
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Rationale, characteristics and study design of PREAMI (Perindopril and Remodelling in the Elderly with Acute Myocardial Infraction)].
    Magrini G; Nicolosi GL; Chiariello M; Ferrari R; Remme P; Tavazzi L
    Ital Heart J; 2005 Nov; 6 Suppl 7():14S-23S. PubMed ID: 16485513
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preventive treatment of asymptomatic left ventricular dysfunction following myocardial infarction.
    Sharpe N; Murphy J; Smith H; Hannan S
    Eur Heart J; 1990 Apr; 11 Suppl B():147-56. PubMed ID: 2142081
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Survival and Ventricular Enlargement (SAVE) study: rationale and perspective.
    Pfeffer MA
    Herz; 1993 Dec; 18 Suppl 1():430-5. PubMed ID: 8125423
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effect of captopril on mortality and morbidity in patients with dysfunction of the left ventricle after myocardial infarction. Results on survival and hypertrophic studies].
    Pfeffer MA; Braunvald Iu; Moĭe LA; Basta L; Braun EDzh ; Kaddi TE; Dévis BR; Geltman EM; Goldman S; Fleĭker GS
    Kardiologiia; 1993; 33(12):14-23, 3. PubMed ID: 7910865
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasma brain natriuretic peptide as an indicator for angiotensin-converting-enzyme inhibition after myocardial infarction.
    Motwani JG; McAlpine H; Kennedy N; Struthers AD
    Lancet; 1993 May; 341(8853):1109-13. PubMed ID: 8097802
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Early prevention of left ventricular dysfunction after myocardial infarction with angiotensin-converting-enzyme inhibition.
    Sharpe N; Smith H; Murphy J; Greaves S; Hart H; Gamble G
    Lancet; 1991 Apr; 337(8746):872-6. PubMed ID: 1672967
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Early treatment of acute myocardial infarction with angiotensin-converting enzyme inhibition: safety considerations. SMILE pilot study working party.
    Ambrosioni E; Borghi C; Magnani B
    Am J Cardiol; 1991 Nov; 68(14):101D-110D. PubMed ID: 1746414
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cardiovascular death and left ventricular remodeling two years after myocardial infarction: baseline predictors and impact of long-term use of captopril: information from the Survival and Ventricular Enlargement (SAVE) trial.
    St John Sutton M; Pfeffer MA; Moye L; Plappert T; Rouleau JL; Lamas G; Rouleau J; Parker JO; Arnold MO; Sussex B; Braunwald E
    Circulation; 1997 Nov; 96(10):3294-9. PubMed ID: 9396419
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.